Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Oct-23 4:06 PM View:  | Summit Therapeutics Inc. (SMMT) | 13-Oct-23 | Private Purchase | 2,976,190 | $1.68 | $5,000,000.00 | 100% 0 to 2.98M | |
| 26-Sep-23 4:30 PM View: | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 62,621 | -- | -- | (100%) 62.62K to 0 | |
| 17-Aug-23 4:43 PM View: | Reata Pharmaceuticals Inc (RETA) | 16-Aug-23 | Private Sale | 1,755 | $168.41 | $295,566.00 | (3%) 64.38K to 62.62K | |
| 01-Aug-23 4:47 PM View: | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Conversion | 75,000 | -- | -- | 117% 64.38K to 139.38K | |
| 01-Aug-23 4:47 PM View: | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Sale (Planned) | 75,000 | $164.62 | $12,346,300.00 | (54%) 139.38K to 64.38K | |
| 10-Jul-23 4:47 PM View: | Reata Pharmaceuticals Inc (RETA) | 06-Jul-23 | Grant | 6,000 | -- | -- | 10% 58.38K to 64.38K | |
| 14-Jun-23 4:35 PM View: | Reata Pharmaceuticals Inc (RETA) | 13-Jun-23 | Option Exercise | 25,000 | $27.32 | $683,000.00 | 22% 111.46K to 136.46K | |
| 14-Jun-23 4:35 PM View: | Reata Pharmaceuticals Inc (RETA) | 13-Jun-23 | Option Sale | 20,289 | $102.89 | $2,087,580.00 | (15%) 136.46K to 116.17K | |
| 14-Jun-23 4:35 PM View: | Reata Pharmaceuticals Inc (RETA) | 13-Jun-23 | Sale | 57,796 | $102.89 | $5,946,760.00 | (50%) 116.17K to 58.38K | |
| 14-Jun-23 4:35 PM View: | Reata Pharmaceuticals Inc (RETA) | 12-Jun-23 | Private Option Sale | 4,711 | $99.62 | $469,297.00 | (4%) 116.17K to 111.46K | |
| 17-May-23 4:39 PM View: | Reata Pharmaceuticals Inc (RETA) | 16-May-23 | Sale | 625 | $80.93 | $50,583.80 | (< 1%) 116.8K to 116.17K | |
| 17-May-23 4:39 PM View: | Reata Pharmaceuticals Inc (RETA) | 15-May-23 | Private Sale | 21,507 | $84.56 | $1,818,570.00 | (16%) 138.3K to 116.8K | |
| 09-May-23 4:35 PM View: | Reata Pharmaceuticals Inc (RETA) | 05-May-23 | Grant | 50,000 | -- | -- | 57% 88.3K to 138.3K | |
| 08-Mar-23 5:01 PM View: | Reata Pharmaceuticals Inc (RETA) | 07-Mar-23 | Private Sale | 622 | $84.69 | $52,680.30 | (< 1%) 88.93K to 88.3K | |
| 06-Mar-23 4:48 PM View: | Reata Pharmaceuticals Inc (RETA) | 03-Mar-23 | Private Sale | 3,587 | $87.97 | $315,548.00 | (4%) 92.51K to 88.93K | |
| 04-Jan-23 5:17 PM View: | Reata Pharmaceuticals Inc (RETA) | 03-Jan-23 | Grant | 23,513 | -- | -- | 34% 69.0K to 92.51K | |
| 05-Jan-22 4:07 PM View: | Reata Pharmaceuticals Inc (RETA) | 03-Jan-22 | Grant | 50,000 | -- | -- | 263% 19.0K to 69.0K | |
| 04-Jan-22 8:51 AM View: | Reata Pharmaceuticals Inc (RETA) | 31-Dec-21 | Market Purchase | 16,000 | $26.22 | $419,565.00 | 533% 3.0K to 19.0K | 4% |
| 14-Aug-20 3:45 PM View: | Reata Pharmaceuticals Inc (RETA) | 14-Aug-20 | Market Purchase | 3,000 | $100.21 | $300,630.00 | 100% 0 to 3.0K | (71%) |
| 18-Jun-20 5:07 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 17-Jun-20 | Market Sale (Planned) | 304 | $62.74 | $19,073.00 | (5%) 6.21K to 5.9K | (20%) |
| 16-Jun-20 8:54 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 15-Jun-20 | Market Sale (Planned) | 1,327 | $60.12 | $79,779.20 | (18%) 7.53K to 6.21K | (25%) |
| 16-Jun-20 8:54 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 12-Jun-20 | Grant | 2,446 | -- | -- | 48% 5.09K to 7.53K | |
| 17-Jun-19 6:53 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 14-Jun-19 | Market Sale (Planned) | 1,217 | $55.89 | $68,021.90 | (19%) 6.3K to 5.09K | (35%) |
| 17-Jun-19 6:53 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 13-Jun-19 | Grant | 2,654 | -- | -- | 73% 3.65K to 6.3K | |
| 17-Dec-18 4:25 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 14-Dec-18 | Grant | 3,650 | -- | -- | (200%) (-1.82K) to 1.82K | |
| 14-Aug-18 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Jul-18 | Acquisition (other) | 36 | -- | -- | 77% 47 to 83 | |
| 14-Aug-18 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Apr-18 | Acquisition (other) | 28 | -- | -- | 147% 19 to 47 | |
| 14-Aug-18 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 17-Jan-18 | Acquisition (other) | 6 | -- | -- | 46% 13 to 19 | |
| 14-Aug-18 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Oct-17 | Acquisition (other) | 11 | -- | -- | 550% 2 to 13 | |
| 14-Aug-18 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jul-17 | Acquisition (other) | 2 | -- | -- | 100% 0 to 2 | |
| 16-Feb-17 2:14 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 16-Feb-17 | Disposition | 3,273 | -- | -- | (100%) 3.27K to 0 | |
| 28-May-15 6:35 PM View: | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition | 54,000 | $261.25 | $14,107,500.00 | (98%) 54.87K to 0.87K | |
| 28-May-15 6:35 PM View: | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 873 | $261.25 | $228,071.00 | (100%) 0.87K to 0 | |
| 13-Mar-15 6:25 PM View: | Pharmacyclics Inc. (PCYC) | 13-Mar-15 | Market Sale | 3,416 | $254.90 | $870,756.00 | (6%) 58.03K to 54.61K | (2%) |
| 13-Mar-15 6:25 PM View: | Pharmacyclics Inc. (PCYC) | 11-Mar-15 | Option Exercise | 24,098 | $75.06 | $1,808,850.00 | 42% 58.03K to 82.13K | |
| 13-Mar-15 6:25 PM View: | Pharmacyclics Inc. (PCYC) | 11-Mar-15 | Market Option Sale | 24,098 | $254.15 | $6,124,510.00 | (29%) 82.13K to 58.03K | (3%) |
| 04-Mar-15 7:55 PM View: | Pharmacyclics Inc. (PCYC) | 03-Mar-15 | Payment of Exercise | 2,584 | $216.76 | $560,121.00 | (4%) 60.61K to 58.03K | (21%) |
| 21-Jan-15 5:09 PM View: | Pharmacyclics Inc. (PCYC) | 16-Jan-15 | Grant | 22,000 | -- | -- | 57% 38.61K to 60.61K | |
| 17-Nov-14 4:19 PM View: | Pharmacyclics Inc. (PCYC) | 13-Nov-14 | Option Exercise | 1,000 | $61.60 | $61,600.00 | 3% 38.61K to 39.61K | |
| 17-Nov-14 4:19 PM View: | Pharmacyclics Inc. (PCYC) | 13-Nov-14 | Market Option Sale | 1,000 | $141.44 | $141,442.00 | (3%) 39.61K to 38.61K | (85%) |
| 04-Nov-14 7:16 PM View: | Pharmacyclics Inc. (PCYC) | 31-Oct-14 | Acquisition (other) | 1 | $80.93 | $80.93 | < 1% 38.61K to 38.61K | |
| 23-Jul-14 7:15 PM View: | Pharmacyclics Inc. (PCYC) | 22-Jul-14 | Grant | 6,000 | -- | -- | 18% 32.61K to 38.61K | |
| 01-May-14 7:49 PM View: | Pharmacyclics Inc. (PCYC) | 30-Apr-14 | Acquisition (other) | 204 | $80.39 | $16,399.60 | < 1% 32.41K to 32.61K | |
| 05-Feb-14 4:20 PM View: | Pharmacyclics Inc. (PCYC) | 04-Feb-14 | Grant | 32,000 | -- | -- | 7882% 0.41K to 32.41K | |
| 06-Nov-13 1:42 PM View: | Pharmacyclics Inc. (PCYC) | 31-Oct-13 | Acquisition (other) | 161 | $52.24 | $8,410.80 | 66% 0.24K to 0.41K | |
| 01-May-13 8:35 PM View: | Pharmacyclics Inc. (PCYC) | 30-Apr-13 | Acquisition (other) | 245 | $52.24 | $12,799.00 | 100% 0 to 0.24K |